(1 Vote)

Steering Committee

The high-profile committee guiding the UK PGx Network



Sir Munir Pirmohamed - NHS Chair of Pharmacogenetics, University of Liverpool

Nathan Elsdon - Network Manager, University of Liverpool

Ann Daly - Professor of Pharmacogenetics, Newcastle University

Chris Chamberlain - Merck Germany

Doris-Ann Williams - Chief Executive, BIVDA

Eddie Blair - UCB

Edward Blandford - Department of Health, Office for Life Science

Ellen McDonagh - Open Targets, EMBL-EBI

Ewan Pearson - Professor of Diabetic Medicine, Dundee University

Karen Spink - Innovate UK

Krishna Prasad - Clinical Assessor, MHRA

Philippa Brice - PHG Foundation

Richard Evans - MRC

Sheuli Porkess - ABPI



The Pharmacogenetics and Stratified Medicines Network was set up to develop a truly multidisciplinary organisation to facilitate collaboration between clinical and academic stratified medicine researchers with the pharmaceutical industry / regulatory sectors and patients

Terms of Reference

  • Help define and formulate the remit and role of the UK Pharmacogenetics and Stratified Medicines network
  • Develop the programme for the Network annual meeting and workshops
  • Disseminate information about the network to encourage membership and promote attendance to events
  • Advise on the development and content of the network website
  • Facilitate interaction and engagement across the life science community which researches, develops, evaluates, commissions and practices stratified medicine
  • Proactively develop policies to strengthen the UK environment, and global standing, for stratified medicine
  • Further expand the network to become a global organisation
  • Identify funding opportunities for UK pharmacogenetics and stratified medicines researchers, including in the EU and US
  • Interact on social media, Facebook, Twitter, Google plus, Pinterest, etc.


Contact Us

University of Liverpool

Block A: Waterhouse Buildings

1-5 Brownlow Street

Liverpool L69 3GL



Follow us